the epithelial-to-mesenchymal transition (EMt) converts epithelial cells into mesenchymal cells that are able to invade and migrate. in the context of cancer pathogenesis, the EMt contributes to metastatic progression (thiery, 2002; acloque et al, 2008) . one of the characteristics of EMt is the functional loss of E-cadherin, which is crucial for the progression to invasive carcinoma (perl et al, 1998) . transcriptional repression has emerged as a fundamental mechanism for E-cadherin loss during EMt and several repressors have been characterized. these include zinc-finger E-box-binding homeobox 1 (zEB1), zEB2/Sip1, Snail1, Snail2 and twist, which strongly repress E-cadherin transcription through their direct binding to the E-box motifs within the E-cadherin promoter (Barrallo-gimeno & nieto, 2005; peinado et al, 2007) . During the past decade, it has emerged that micrornas (mirnas) are a fundamental mechanism of gene-expression regulation, and several recent reports have shown that these small molecules are involved in the control of E-cadherin expression in cancer cells and tumours (Hurteau et al, 2007; christoffersen et al, 2007; gregory et al, 2008; park et al, 2008) . Furthermore, in this issue of EMBO reports, Burk and colleagues have provided a beautiful example of gene regulation in which mirnas and transcription factors are linked to one another in a gene-regulatory network to control E-cadherin expression and the invasive phenotype in cancer cells (Burk et al, 2008) .
Mirnas regulate gene expression through binding to mrna target sequences typically in their 3' untranslated regulatory regions (utrs), which results in the degradation of target mrnas and/or the inhibition of the translation process (Filipowicz et al, 2008) . Several mirnas are deregulated or mutated in many human cancers, including lung, breast, brain, liver and colon cancers, making them attractive targets in biomedical research and anti-tumour therapies (Esquela-Kerscher & Slack, 2006; zhang et al, 2007; couzin, 2008) .
Mirnas can function as tumour promoters or as tumour suppressors. For example, mir-10b, mir-373 and mir-520c are highly expressed in metastatic breast cancer cells in which they positively regulate cell migration, invasion and metastatic properties (Ma et al, 2007; Huang et al, 2008) . Similarly, mir-21 is increased in breast and colon carcinomas and is upregulated during the transforming growth factor-β (tgFβ)-induced EMt in cancer-derived cell lines (zavadil et al, 2007) . conversely, tavazoie and colleagues showed that mir-126, mir-206 and mir-335 suppress breast cancer metastasis (tavazoie et al, 2007) , and they were able to confirm clinical relevance for mir-126 and mir-335. Similarly, let-7 is a marker for differentiated cancers and seems to impair tumour progression by preventing the re-expression of early embryonic genes during the initial steps of neoplastic transformation. However, let-7 is unlikely to be an EMt regulator as its expression cannot be associated with changes in the expression of EMt markers (Shell et al, 2007; park et al, 2007) .
given the relevance of both EMt and mirnas in tumour progression, the question became whether other mirnas had a role in the induction of EMt. indeed, two recent reports indicate that the EMt inducers zEB1 and zEB2/Sip1 are direct targets of mir-200 family members, suggesting that mirnas can indirectly regulate E-cadherin expression in tumour cell lines (christoffersen et al, 2007; Hurteau et al, 2007) . two additional comprehensive studies have now confirmed that members of the mir-200 family directly repress the zEB1 and zEB2/Sip1 factors in a cooperative manner, and that there is a strong correlation between the expression of mir-200 and that of E-cadherin in several cancer cell lines and human tumours (gregory et al, 2008; park et al, 2008) . conversely, the expression of the mir-200 family is lost in mesenchymal and invasive cells, as it is in poorly differentiated and aggressive metaplastic breast cancers. interestingly, the silencing of mir-200 family members is sufficient to induce EMt and invasion in epithelial cell lines, whereas their overexpression can trigger the reverse process-the mesenchymal-to-epithelial transition (MEt; gregory et al, 2008; park et al, 2008) . these data suggest that the loss of the mir-200 family might be crucial for the induction of EMt during tumour progression.
once it had been established that the mir-200 family represses Zeb gene transcription, and given that several family members are lost in invasive carcinomas, Burk and colleagues took one step further and asked whether the forced downregulation of zEB1 modifies mirna expression in cancer cells (Fig 1a; Burk et al, 2008) . they found that the mir-200 family members mirna-200c and mirna-141 are upregulated, and that their putative regulatory elements contain several binding sequences for zEB1, some of which can also be recognized by other EMt inducers. indeed, zEB1 directly suppresses the transcription of mir-200c and mir-141, giving rise to a negative-feedback loop of transcriptional coregulation of mirnas and their targets as previously modelled by tsang and colleagues (Fig 1B; tsang et al, 2007) . interestingly, mir-141 also represses the EMt inducer tgFβ2 (Burk et al, 2008) , perhaps reinforcing the epithelial state. indeed, the normal epithelial condition is characterized by high levels of mir-200 that maintain high E-cadherin levels and tissue homeostasis. in cancer cells, the increase in the signals that activate Zeb genes and other EMt inducers might overcome this control and favour the transition to the mesenchymal state.
the past few months have witnessed the emergence of a plethora of studies linking mirnas with tumour invasion and metastasis. a tight connection between the mir-200 family and EMt in tumour progression has unveiled how transcription factors and mirnas are linked to one another in gene-regulatory networks. this network might function to maintain epithelial homeostasis or to trigger a zEB1 
